Single-Molecule Drug Discovery Platform for Enzyme Interaction Detection

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Conventional drug screening methods are limited in their ability to efficiently detect and validate promising drug candidates that interfere with target enzymes, particularly polymerases, RNA polymerases, and reverse transcriptases, which are crucial for developing anti-viral, anti-cancer, and antibiotic drugs.

Innovation Solution

The use of single-molecule manipulation and detection technologies, such as optical or magnetic tweezers, to directly observe and analyze the mechanical signatures of enzyme-substrate interactions in the presence of drug candidates, allowing for rapid identification of interference mechanisms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional drug screening methods are used, then drug discovery can proceed with standard protocols, but the detection and validation of promising drug candidates is slow and inefficient

Engineering Contradiction:

Improvedrug candidate detection efficiencyVSAvoidtime for drug discovery

Core Design Contradiction:

ProductivityVSLoss of time

Solution Approach 1:

The patent replaces conventional biochemical and cellular assays with single-molecule manipulation and detection technologies. Optical tweezers and magnetic tweezers are used to directly manipulate and detect the mechanical signatures of enzyme-substrate interactions at the single-molecule level, enabling real-time observation of drug candidate effects on target enzymes without requiring population-level measurements or complex assay protocols.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces mechanical signatures as an intermediary parameter to detect drug candidate interference mechanisms. By measuring changes in the mechanical properties (such as force, extension, or movement) of enzyme-substrate complexes under single-molecule manipulation, the system translates biochemical interactions into mechanically detectable signals that reveal drug action mechanisms.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Productivity

If single-molecule manipulation and detection technologies are used, then rapid detection and validation of drug candidates is enabled, but the device complexity increases

Engineering Contradiction:

Improvedrug candidate validation speedVSAvoidcomplexity of detection apparatus

Core Design Contradiction:

ProductivityVSDevice complexity

Solution Approach 1:

The patent employs optical tweezers and magnetic tweezers as universal single-molecule manipulation platforms that can study multiple different target enzymes (DNA polymerases, RNA polymerases, reverse transcriptases) using the same basic apparatus. These multi-functional tools allow the system to manipulate various enzyme-substrate complexes through their common mechanical properties without requiring enzyme-specific customization of the detection system.

Inventive Principle:

Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid detection and validation of drug candidates that modulate enzyme activity, significantly reducing the time and cost of drug discovery by focusing on specific interference mechanisms, thereby increasing the likelihood of successful candidates entering clinical trials.

Implementation Method 1

The use of single-molecule manipulation and detection technologies, such as optical or magnetic tweezers

Methodology Applied

Scientific EffectOptical tweezers: Optical Tweezers

Implementation Method 2

The use of single-molecule manipulation and detection technologies, such as optical or magnetic tweezers

Methodology Applied

Scientific EffectMagnetic tweezers: Magnetism

Data Source

PatentUS12435351B2Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents

Publication Date: 2025.10.07 NANOBIOSYM INC

AI summary

One aspect of the invention provides a system for drug discovery, drug development, drug screening, or drug validation. The system includes: a sample chamber comprising a target protein and a drug candidate that may interfere with the target protein in the sample chamber, wherein the sample chamber is configured to: detect one or more of the following: (a) interference between the drug candidate the target protein and/or (b) one or more dynamics of the drug candidate on the target protein, wherein the one or more dynamics comprise affinity of the drug candidate to the target protein, and select the drug candidate if one or more desirable dynamics is detected. The system includes one or more immobilized surfaces and is configured to detect interactions between the drug candidate and the target protein at the single-molecule level.